PRTC: PureTech Health plc Stocks News on September 10, 2025

Vor, with new CEO, changes course to target autoimmune disease

PRTC

BioPharma Dive

2 months ago

Vor, with new CEO, changes course to target autoimmune disease

PureTech Founded Entity Vor Bio Announces Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset and $175 Million Private Placement

PRTC

Business Wire

2 months ago

PureTech Founded Entity Vor Bio Announces Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset and $175 Million Private Placement

PureTech Health: Results of Annual General Meeting

PRTC

Business Wire

3 months ago

PureTech Health: Results of Annual General Meeting

PureTech to Present at the Jefferies Global Healthcare Conference

PRTC

Business Wire

4 months ago

PureTech to Present at the Jefferies Global Healthcare Conference

PureTech’s Deupirfenidone (LYT-100) Demonstrates Strong and Durable Efficacy as a Monotherapy with Favorable Tolerability in Phase 2b ELEVATE IPF Trial

PRTC

Business Wire

4 months ago

PureTech’s Deupirfenidone (LYT-100) Demonstrates Strong and Durable Efficacy as a Monotherapy with Favorable Tolerability in Phase 2b ELEVATE IPF Trial

PureTech Announces Publication of New Research Highlighting Untold Experiences of People Living with Idiopathic Pulmonary Fibrosis (IPF)

PRTC

Business Wire

4 months ago

PureTech Announces Publication of New Research Highlighting Untold Experiences of People Living with Idiopathic Pulmonary Fibrosis (IPF)

PRTC

Simply Wall St.

4 months ago

Shareholders In PureTech Health (LON:PRTC) Should Look Beyond Earnings For The Full Story

PureTech Health PLC (PTCHF) (FY 2024) Earnings Call Highlights: Strong Financial Execution and ...

PRTC

GuruFocus.com

4 months ago

PureTech Health PLC (PTCHF) (FY 2024) Earnings Call Highlights: Strong Financial Execution and ...

PureTech to Present Results from Phase 2b ELEVATE IPF Trial of Deupirfenidone (LYT-100) at the American Thoracic Society International Conference

PRTC

Business Wire

4 months ago

PureTech to Present Results from Phase 2b ELEVATE IPF Trial of Deupirfenidone (LYT-100) at the American Thoracic Society International Conference

PureTech Announces Annual Results for Year Ended December 31, 2024

PRTC

Business Wire

4 months ago

PureTech Announces Annual Results for Year Ended December 31, 2024

PRTC

Business Wire

5 months ago

PureTech Health: Notice of Results

PureTech Appoints Peel Hunt as Joint UK Corporate Broker

PRTC

Business Wire

5 months ago

PureTech Appoints Peel Hunt as Joint UK Corporate Broker

PRTC

MT Newswires

5 months ago

Sector Update: Health Care Stocks Slipping in Afternoon Trading

PRTC

MT Newswires

5 months ago

PureTech Health Confirms Takeover Speculations

PureTech Health plc Statement Regarding Press Speculation

PRTC

Business Wire

5 months ago

PureTech Health plc Statement Regarding Press Speculation

PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

PRTC

Business Wire

6 months ago

PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

PureTech to Present at the Leerink Partners Global Healthcare Conference

PRTC

Business Wire

7 months ago

PureTech to Present at the Leerink Partners Global Healthcare Conference

PureTech Founded Entity Seaport Therapeutics Announces the Publication of New Research Demonstrating Increased Lymphatic Transport with up to 55 Percent Drug Absorption via Lymphatics with GlyphTM Platform

PRTC

Business Wire

7 months ago

PureTech Founded Entity Seaport Therapeutics Announces the Publication of New Research Demonstrating Increased Lymphatic Transport with up to 55 Percent Drug Absorption via Lymphatics with GlyphTM Platform

PRTC

MT Newswires

7 months ago

Top Premarket Gainers

PureTech Founded Vedanta Biosciences Publishes Additional Phase 2 VE303 Results in Nature Medicine

PRTC

Business Wire

7 months ago

PureTech Founded Vedanta Biosciences Publishes Additional Phase 2 VE303 Results in Nature Medicine

PureTech announces receipt of FDA Fast Track Designation for LYT-200 in AML

PRTC

TipRanks

8 months ago

PureTech announces receipt of FDA Fast Track Designation for LYT-200 in AML

PRTC

MT Newswires

8 months ago

PureTech Health Gets US FDA Fast Track Designation for LYT-200 to Treat Acute Myeloid Leukemia

PureTech Receives FDA Fast Track Designation for LYT-200 in Acute Myeloid Leukemia (AML)

PRTC

Business Wire

8 months ago

PureTech Receives FDA Fast Track Designation for LYT-200 in Acute Myeloid Leukemia (AML)

PureTech to Present at 43rd Annual J.P. Morgan Healthcare Conference

PRTC

Business Wire

8 months ago

PureTech to Present at 43rd Annual J.P. Morgan Healthcare Conference

PureTech Appoints UBS as UK Corporate Broker

PRTC

Business Wire

8 months ago

PureTech Appoints UBS as UK Corporate Broker

PureTech's Lung Disease Candidate Slowed Lung Function Decline In Idiopathic Pulmonary Fibrosis Patients

PRTC

Benzinga

9 months ago

PureTech's Lung Disease Candidate Slowed Lung Function Decline In Idiopathic Pulmonary Fibrosis Patients

PRTC

MT Newswires

9 months ago

Sector Update: Health Care Stocks Mixed Pre-Bell Monday

PRTC

MT Newswires

9 months ago

PureTech Health Says Trial of Potential Lung Fibrosis Treatment Meets Primary Endpoint

PureTech’s Deupirfenidone (LYT-100) Slowed Lung Function Decline in People with Idiopathic Pulmonary Fibrosis (IPF) as Measured by Forced Vital Capacity (FVC), Achieving the Primary and Key Secondary Endpoints in the ELEVATE IPF Phase 2b Trial

PRTC

Business Wire

9 months ago

PureTech’s Deupirfenidone (LYT-100) Slowed Lung Function Decline in People with Idiopathic Pulmonary Fibrosis (IPF) as Measured by Forced Vital Capacity (FVC), Achieving the Primary and Key Secondary Endpoints in the ELEVATE IPF Phase 2b Trial

PRTC

Simply Wall St.

9 months ago

With 71% institutional ownership, PureTech Health plc (LON:PRTC) is a favorite amongst the big guns

PureTech Founded Entity Seaport Therapeutics Presents Additional Data from Phase 1 Study of SPT-300 at ACNP Annual Meeting 2024

PRTC

Business Wire

9 months ago

PureTech Founded Entity Seaport Therapeutics Presents Additional Data from Phase 1 Study of SPT-300 at ACNP Annual Meeting 2024

$PureTech Presents Data for LYT-200 (anti-galectin-9 monoclonal antibody) for Relapsed/Refractory AML/MDS at the 2024 ASH Annual Meeting$

PRTC

Business Wire

9 months ago

PureTech Presents Data for LYT-200 (anti-galectin-9 monoclonal antibody) for Relapsed/Refractory AML/MDS at the 2024 ASH Annual Meeting

PureTech Founded Entity Seaport Therapeutics Adds Sandi Peterson to its Board of Directors

PRTC

Business Wire

10 months ago

PureTech Founded Entity Seaport Therapeutics Adds Sandi Peterson to its Board of Directors

PureTech Founded Entity Seaport Therapeutics Names Lauren White as Chief Financial Officer

PRTC

Business Wire

10 months ago

PureTech Founded Entity Seaport Therapeutics Names Lauren White as Chief Financial Officer

PureTech to Present at Two Upcoming Investor Conferences

PRTC

Business Wire

10 months ago

PureTech to Present at Two Upcoming Investor Conferences

PRTC

MT Newswires

a year ago

PureTech Health's Seaport Therapeutics Closes $225 Million in Oversubscribed Series B Financing

PureTech thinks the ‘hub-and-spoke’ startup model is still a good bet. If only investors agreed.

PRTC

BioPharma Dive

a year ago

PureTech thinks the ‘hub-and-spoke’ startup model is still a good bet. If only investors agreed.

PureTech Founded Entity Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round

PRTC

Business Wire

a year ago

PureTech Founded Entity Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round

PRTC

The Wall Street Journal

a year ago

Corrections & Amplifications

PureTech Presents Research Highlighting Burden of Idiopathic Pulmonary Fibrosis (IPF) and Use of a Bayesian Statistical Analysis for LYT-100 (Deupirfenidone) at CHEST 2024 Annual Meeting

PRTC

Business Wire

a year ago

PureTech Presents Research Highlighting Burden of Idiopathic Pulmonary Fibrosis (IPF) and Use of a Bayesian Statistical Analysis for LYT-100 (Deupirfenidone) at CHEST 2024 Annual Meeting

PureTech to Present at CHEST 2024 Annual Meeting

PRTC

Business Wire

a year ago

PureTech to Present at CHEST 2024 Annual Meeting

FDA approves PureTech’s KarXT to treat schizophrenia in adults

PRTC

Pharmaceutical Technology

a year ago

FDA approves PureTech’s KarXT to treat schizophrenia in adults

PRTC

MT Newswires

a year ago

PureTech Earns $29 Million Milestone Payment From FDA Approval of Schizophrenia Treatment

PureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults

PRTC

Business Wire

a year ago

PureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults

PureTech Founded Entity Vor Bio Announces New Clinical Data Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies

PRTC

Business Wire

a year ago

PureTech Founded Entity Vor Bio Announces New Clinical Data Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies

PRTC

Business Wire

a year ago

PureTech Health plc – Half-Year Report

PureTech Appoints Michele Holcomb, PhD, to Board of Directors

PRTC

Business Wire

a year ago

PureTech Appoints Michele Holcomb, PhD, to Board of Directors

PureTech Health: Notice of Half-Yearly Results

PRTC

Business Wire

a year ago

PureTech Health: Notice of Half-Yearly Results

PureTech Founded Entity Seaport Therapeutics Appoints David Wheadon, M.D., to its Board of Directors

PRTC

Business Wire

a year ago

PureTech Founded Entity Seaport Therapeutics Appoints David Wheadon, M.D., to its Board of Directors

PureTech Founded Entity Vedanta Biosciences Expands Leadership Team and Appoints Head of Commercial

PRTC

Business Wire

a year ago

PureTech Founded Entity Vedanta Biosciences Expands Leadership Team and Appoints Head of Commercial

PureTech Health: Completion of Tender Offer & Total Voting Rights

PRTC

Business Wire

a year ago

PureTech Health: Completion of Tender Offer & Total Voting Rights

PureTech Health: Results of the Tender Offer

PRTC

Business Wire

a year ago

PureTech Health: Results of the Tender Offer

PRTC

MT Newswires

a year ago

PureTech Health Names Raju Kucherlapati as Chair

PRTC

Business Wire

a year ago

PureTech Announces Change of Board Role

PureTech Founded Entity Seaport Therapeutics Appoints Seasoned Executives to Management Team

PRTC

Business Wire

a year ago

PureTech Founded Entity Seaport Therapeutics Appoints Seasoned Executives to Management Team

PRTC

Business Wire

a year ago

PureTech Health: Results of Annual General Meeting

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

PRTC

Business Wire

a year ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

PRTC

GlobeNewswire

a year ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

PRTC

GlobeNewswire

a year ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

PRTC

Simply Wall St.

a year ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May

PRTC

Reuters

a year ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

PRTC

AFP

a year ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

PRTC

GlobeNewswire

a year ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

Enduring role of 'treasuring the past' hailed

PRTC

PR Newswire

a year ago

Enduring role of 'treasuring the past' hailed

IBD Stock Of The Day Meta Rolls Out New AI Tools For Businesses

PRTC

Investor's Business Daily

a year ago

IBD Stock Of The Day Meta Rolls Out New AI Tools For Businesses

Credo AI Launches the World's Largest and Most Comprehensive AI Risk and Controls Library

PRTC

Business Wire

a year ago

Credo AI Launches the World's Largest and Most Comprehensive AI Risk and Controls Library

Dow Jones Futures: Apple AI Launch, Tesla Shareholder Meeting, Fed Rate 'Dot Plot' On Tap

PRTC

Investor's Business Daily

a year ago

Dow Jones Futures: Apple AI Launch, Tesla Shareholder Meeting, Fed Rate 'Dot Plot' On Tap

EnviroGold Global Closes First Tranche of Private Placement

PRTC

GlobeNewswire

a year ago

EnviroGold Global Closes First Tranche of Private Placement

Insider Sale: Director Carol Lowe Sells Shares of EMCOR Group Inc (EME)

PRTC

GuruFocus.com

a year ago

Insider Sale: Director Carol Lowe Sells Shares of EMCOR Group Inc (EME)

How markets digested hot jobs print: Top takeaways

PRTC

Yahoo Finance Video

a year ago

How markets digested hot jobs print: Top takeaways

SoCalGas Volunteers to Help Sort 1.8 Million Pounds of Food to Help Labor Community Services "Stamp Out Hunger"

PRTC

PR Newswire

a year ago

SoCalGas Volunteers to Help Sort 1.8 Million Pounds of Food to Help Labor Community Services "Stamp Out Hunger"

Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders

PRTC

GlobeNewswire

a year ago

Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders

PureTech Health: Result of General Meeting

PRTC

Business Wire

a year ago

PureTech Health: Result of General Meeting

PRTC

MT Newswires

a year ago

PureTech Health's Akili, Virtual Therapeutics Sign Merger Deal to Launch Digital Health Company

PureTech Founded Entity Akili Interactive and Virtual Therapeutics Announce Entering Into Definitive Merger Agreement to Establish Leading Digital Health Company

PRTC

Business Wire

a year ago

PureTech Founded Entity Akili Interactive and Virtual Therapeutics Announce Entering Into Definitive Merger Agreement to Establish Leading Digital Health Company

PRTC

Business Wire

a year ago

PureTech to Present at the Jefferies Global Healthcare Conference

PureTech Founded Entity Vedanta Biosciences Enrolls First Patient in Pivotal Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile Infection

PRTC

Business Wire

a year ago

PureTech Founded Entity Vedanta Biosciences Enrolls First Patient in Pivotal Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile Infection

PRTC

MT Newswires

a year ago

PureTech Health Opens $100 Million Buyback Program

PureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary Share

PRTC

Business Wire

a year ago

PureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary Share

PureTech Founded Entity Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual Meeting

PRTC

Business Wire

a year ago

PureTech Founded Entity Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual Meeting

PureTech Founded Entity Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive Appointments

PRTC

Business Wire

a year ago

PureTech Founded Entity Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive Appointments

PRTC

Insider Monkey

a year ago

PureTech Health plc (NASDAQ:PRTC) Q4 2023 Earnings Call Transcript

PureTech Announces Annual Results for Year Ended December 31, 2023

PRTC

Business Wire

a year ago

PureTech Announces Annual Results for Year Ended December 31, 2023

PRTC

Business Wire

a year ago

PureTech Health: Notice of Results

PureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary Fibrosis

PRTC

Business Wire

a year ago

PureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary Fibrosis

PureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck Cancers

PRTC

Business Wire

a year ago

PureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck Cancers

PureTech launches Seaport, hoping to create Karuna 2.0

PRTC

BioPharma Dive

a year ago

PureTech launches Seaport, hoping to create Karuna 2.0

PureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management Transitions

PRTC

Business Wire

a year ago

PureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management Transitions

PRTC

Zacks

a year ago

PureTech Health (PRTC) is on the Move, Here's Why the Trend Could be Sustainable

PureTech Proposes $100 Million Capital Return

PRTC

Business Wire

a year ago

PureTech Proposes $100 Million Capital Return

Bristol Myers Squibb Completes Acquisition of PureTech's Founded Entity Karuna Therapeutics for $14 Billion

PRTC

Business Wire

a year ago

Bristol Myers Squibb Completes Acquisition of PureTech's Founded Entity Karuna Therapeutics for $14 Billion

PureTech Receives Orphan Drug Designation for LYT-200 in Acute Myeloid Leukemia

PRTC

Business Wire

a year ago

PureTech Receives Orphan Drug Designation for LYT-200 in Acute Myeloid Leukemia

PRTC

Business Wire

2 years ago

PureTech to Present at Two Upcoming Investor Conferences

PureTech Founded Entity Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx ® for Pediatric ADHD Patients in Japan

PRTC

Business Wire

2 years ago

PureTech Founded Entity Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx ® for Pediatric ADHD Patients in Japan

PRTC

Zacks

2 years ago

Down -8.13% in 4 Weeks, Here's Why PureTech Health PLC Sponsored ADR (PRTC) Looks Ripe for a Turnaround

Here's What We Like About Select Water Solutions' (NYSE:WTTR) Upcoming Dividend

PRTC

Simply Wall St.

2 years ago

Here's What We Like About Select Water Solutions' (NYSE:WTTR) Upcoming Dividend

SPR® Therapeutics Announces $85 Million in Additional Funding to Advance Rapid Commercial Expansion of the SPRINT® PNS System

PRTC

GlobeNewswire

2 years ago

SPR® Therapeutics Announces $85 Million in Additional Funding to Advance Rapid Commercial Expansion of the SPRINT® PNS System

Two Harbors Investment Corp. Reports Fourth Quarter 2023 Financial Results

PRTC

Business Wire

2 years ago

Two Harbors Investment Corp. Reports Fourth Quarter 2023 Financial Results

Fortegra Announces Launch of Initial Public Offering

PRTC

PR Newswire

2 years ago

Fortegra Announces Launch of Initial Public Offering

Varex Schedules First Quarter Fiscal Year 2024 Earnings Release and Conference Call

PRTC

Business Wire

2 years ago

Latest PureTech Health plc (PRTC) News on September 10, 2025

Share on Social Networks: